4/29
09:20 am
bpts
Biophytis is Deploying its Partnership Strategy in Obesity [Yahoo! Finance]
Neutral
Report
Biophytis is Deploying its Partnership Strategy in Obesity [Yahoo! Finance]
4/29
09:00 am
bpts
Biophytis is Deploying its Partnership Strategy in Obesity
Neutral
Report
Biophytis is Deploying its Partnership Strategy in Obesity
4/24
05:41 pm
bpts
Biophytis Announces Transfer of ADSs to OTC Market [Yahoo! Finance]
Medium
Report
Biophytis Announces Transfer of ADSs to OTC Market [Yahoo! Finance]
4/24
05:30 pm
bpts
Biophytis Announces Transfer of ADSs to OTC Market
High
Report
Biophytis Announces Transfer of ADSs to OTC Market
4/19
01:34 am
bpts
Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) Program [Yahoo! Finance]
Medium
Report
Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) Program [Yahoo! Finance]
4/19
01:20 am
bpts
Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) Program
Medium
Report
Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) Program
4/18
01:29 am
bpts
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity [Yahoo! Finance]
Medium
Report
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity [Yahoo! Finance]
4/18
01:20 am
bpts
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
Medium
Report
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
4/9
12:17 pm
bpts
Why Is Penny Stock Biophytis Trading Higher On Tuesday? [Yahoo! Finance]
High
Report
Why Is Penny Stock Biophytis Trading Higher On Tuesday? [Yahoo! Finance]
4/9
09:00 am
bpts
Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up [Yahoo! Finance]
Low
Report
Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up [Yahoo! Finance]
4/8
06:27 pm
bpts
Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities [Yahoo! Finance]
High
Report
Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities [Yahoo! Finance]
4/8
06:10 pm
bpts
Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities
High
Report
Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities
4/8
05:44 pm
bpts
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) [Yahoo! Finance]
High
Report
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) [Yahoo! Finance]
4/8
05:30 pm
bpts
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
High
Report
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
4/4
05:39 pm
bpts
Results of the Combined General Meeting on April 2, 2024 [Yahoo! Finance]
Low
Report
Results of the Combined General Meeting on April 2, 2024 [Yahoo! Finance]
4/4
05:00 pm
bpts
Results of the Combined General Meeting on April 2, 2024
Low
Report
Results of the Combined General Meeting on April 2, 2024
3/22
02:34 am
bpts
Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia [Yahoo! Finance]
Medium
Report
Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia [Yahoo! Finance]
3/22
02:20 am
bpts
Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia
Medium
Report
Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia
3/18
05:40 am
bpts
Sarcopenia Market Expected to Grow with Advancements in Treatment and Diagnosis by 2032 [Yahoo! Finance]
Medium
Report
Sarcopenia Market Expected to Grow with Advancements in Treatment and Diagnosis by 2032 [Yahoo! Finance]